Loading viewer...
investor_presentation
Format: PDF investor_presentation
II-VI Incorporated investor presentation from December 2018 discussing the proposed acquisition of Finisar Corporation. The presentation details the transaction rationale, anticipated synergies, integration plans, and associated business and financial considerations.
investor_presentation
19 Pages
investor_presentation
33 Pages
Vedanta Resources
Karyopharm Therapeutics Investor Presentation — February 2022
investor_presentationinvestor_presentation
34 Pages
Karyopharm Therapeutics Inc.